Eirís-Puñal J, Iglesias-Meleiro J M, Blanco-Barca M O, Fuster-Siebert M, Barros-Angueira F, Ansede A, Castro-Gago M
Departamento de Pediatría, Servicio de Neuropediatría, Hospital Clínico Universitario de Santiago de Compostela, Santiago de Compostela, España.
Rev Neurol. 2003;37(7):601-7.
The microdeletion 22q11.2 affects 1/4000 live births and constitutes the most frequent interstitial chromosomal alteration in humans. It is involved in a heterogeneous series of phenotypic expressions.
To determine the most important clinical characteristics in a series of patients with this genetic molecular disorder.
We conducted a retrospective study of 16 patients who had been diagnosed, by means of FISH or PCR, as having microdeletion 22q11.2, and the following data were evaluated in a protocolised manner: sex, age, family background, characteristics of the pregnancy, birth, neonatal and post-neonatal periods, clinical and semiological data, as well as the results from the complementary explorations carried out according to the predominant pathology.
The age at which the diagnosis was made oscillated between newly born and 8 years, with a predominance of males over females in a ratio of 3.2/1. In all, 81% of patients presented neurological disorders. Brain malformations were seen in six, hypoplasia of the anguli oris muscle in five, congenital facial palsy in three which was associated with brain malformations in one patient, retarded neurodevelopment in six cases and neurogenic arthrogryposis in one. Other findings such as congenital heart disease (75%), skeletal disorders (37%), peculiar phenotypes (31%), nephrourological disorders (19%) and hypoacusis (19%) constitute significant manifestations of the process. Some of the most noteworthy occasional events include retarded height and weight development, hypocalcemia and cleft palate. In one case involving a child whose mother suffered from chronic alcoholism, there were both phenotypic traits of this entity and of foetal alcohol syndrome at the same time. In four of the patients the FISH technique did not detect the deletion, which was confirmed by a technique involving DNA amplification with PCR.
The presence of central and peripheral neurological alterations, together with cardiac, skeletal, renal and auditory disorders was confirmed, as was the existence of neurodevelopmental retardation and a peculiar phenotype. Both the frequency and the kind of disorder coincided with what has been described earlier. A number of facts stand out owing to their novelty. These include the high incidence of asymmetric crying facies, the existence of data compatible with foetal alcohol syndrome in one of the patients with this clinical entity, and the association with neurogenic arthrogryposis in another, which are circumstances that suggest the possibility of a causal relation with the deletion 22q11.2. Using DNA amplification with PCR is seen to be of greater diagnostic efficacy than the FISH technique.
22q11.2微缺失影响1/4000的活产儿,是人类最常见的间质性染色体改变。它与一系列异质性的表型表达有关。
确定一系列患有这种基因分子疾病的患者的最重要临床特征。
我们对16例经荧光原位杂交(FISH)或聚合酶链反应(PCR)诊断为22q11.2微缺失的患者进行了回顾性研究,并以标准化方式评估了以下数据:性别、年龄、家族背景、妊娠、出生、新生儿期和新生儿后期的特征、临床和症状学数据,以及根据主要病理进行的辅助检查结果。
确诊年龄在新生儿至8岁之间波动,男性多于女性,比例为3.2/1。总体而言,81%的患者出现神经障碍。6例有脑畸形,5例有口角肌发育不全,3例有先天性面瘫,其中1例与脑畸形相关,6例有神经发育迟缓,1例有神经源性关节挛缩。其他发现如先天性心脏病(75%)、骨骼疾病(37%)、特殊表型(31%)、肾泌尿系统疾病(19%)和听力减退(19%)是该疾病的重要表现。一些最值得注意的偶发事件包括身高和体重发育迟缓、低钙血症和腭裂。在1例母亲患有慢性酒精中毒的儿童病例中,同时存在该疾病和胎儿酒精综合征的表型特征。4例患者的FISH技术未检测到缺失,经PCR DNA扩增技术得以证实。
证实存在中枢和外周神经改变,以及心脏、骨骼、肾脏和听觉障碍,同时存在神经发育迟缓及特殊表型。疾病的频率和类型与先前描述的一致。一些事实因其新颖性而突出。这些包括不对称哭泣面容的高发生率、在患有这种临床疾病的1例患者中存在与胎儿酒精综合征相符的数据,以及在另1例中与神经源性关节挛缩的关联,这些情况提示与22q11.2缺失可能存在因果关系。使用PCR DNA扩增技术比FISH技术具有更高的诊断效能。